LIXTE Biotechnology Provides Update On Recent Activities and Developments
Provided By GlobeNewswire
Last update: Aug 19, 2024
-Collaboration with NKI and Funding Support for New Colorectal Cancer Clinical Trial by Major Pharma Company-
-Distinguished Oncologist Jan Schellens Joins LIXTE as Chief Medical Officer-
Read more at globenewswire.com0.2982
-0.03 (-9.64%)
3.97
-0.25 (-5.92%)
Find more stocks in the Stock Screener
